{"id":"https://openalex.org/W2012067775","doi":"https://doi.org/10.1211/0022357011775488","title":"Effect of indinavir on the pharmacokinetics of rifampicin in HIV-infected patients","display_name":"Effect of indinavir on the pharmacokinetics of rifampicin in HIV-infected patients","alternate_titles":[],"publication_year":2001,"publication_date":"2001-03-01","ids":{"openalex":"https://openalex.org/W2012067775","doi":"https://doi.org/10.1211/0022357011775488","mag":"2012067775","pmid":"https://pubmed.ncbi.nlm.nih.gov/11291758"},"language":"en","primary_location":{"id":"doi:10.1211/0022357011775488","doi":"https://doi.org/10.1211/0022357011775488","is_oa":false,"landing_page_url":"https://doi.org/10.1211/0022357011775488","pdf_url":null,"source":{"id":"https://openalex.org/S118304455","display_name":"Journal of Pharmacy and Pharmacology","issn_l":"0022-3573","issn":["0022-3573","2042-7158"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmacy and Pharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2012067775"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5021729591","display_name":"Sutep Jaruratanasirikul","orcid":"https://orcid.org/0000-0002-8411-1407","observed_orcids":["https://orcid.org/0000-0002-8411-1407"]},"institutions":[{"id":"https://openalex.org/I131868736","display_name":"Prince of Songkla University","ror":"https://ror.org/0575ycz84","country_code":"TH","type":"education","lineage":["https://openalex.org/I131868736"]}],"countries":["TH"],"is_corresponding":true,"raw_author_name":"Sutep Jaruratanasirikul","raw_affiliation_strings":["Division of Clinical Pharmacology, Department of Medicine, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkla, 90110, Thailand"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Clinical Pharmacology, Department of Medicine, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkla, 90110, Thailand","institution_ids":["https://openalex.org/I131868736"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5072085465","display_name":"Somchai Sriwiriyajan","orcid":"https://orcid.org/0000-0003-4933-4434","observed_orcids":["https://orcid.org/0000-0003-4933-4434"]},"institutions":[{"id":"https://openalex.org/I131868736","display_name":"Prince of Songkla University","ror":"https://ror.org/0575ycz84","country_code":"TH","type":"education","lineage":["https://openalex.org/I131868736"]}],"countries":["TH"],"is_corresponding":false,"raw_author_name":"Somchai Sriwiriyajan","raw_affiliation_strings":["Division of Clinical Pharmacology, Department of Medicine, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkla, 90110, Thailand"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Clinical Pharmacology, Department of Medicine, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkla, 90110, Thailand","institution_ids":["https://openalex.org/I131868736"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5021729591"],"corresponding_institution_ids":["https://openalex.org/I131868736"],"apc_list":{"value":2911,"currency":"GBP","value_usd":3839},"apc_paid":null,"fwci":0.3678,"has_fulltext":false,"cited_by_count":9,"citation_normalized_percentile":{"value":0.52965613,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"53","issue":"3","first_page":"409","last_page":"412"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9398999810218811,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9398999810218811,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.03750000149011612,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.0044999998062849045,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/indinavir","display_name":"indinavir","score":1.0},{"id":"https://openalex.org/keywords/rifampicin","display_name":"rifampicin","score":1.0},{"id":"https://openalex.org/keywords/drug-drug-interactions","display_name":"drug-drug interactions","score":0.8610000014305115},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8410000205039978},{"id":"https://openalex.org/keywords/cytochrome-p450-inhibition","display_name":"cytochrome P450 inhibition","score":0.9169999957084656},{"id":"https://openalex.org/keywords/hiv-infection","display_name":"HIV infection","score":0.9409999847412109},{"id":"https://openalex.org/keywords/tuberculosis-treatment","display_name":"tuberculosis treatment","score":0.8399999737739563},{"id":"https://openalex.org/keywords/antiretroviral-therapy","display_name":"antiretroviral therapy","score":0.906000018119812},{"id":"https://openalex.org/keywords/auc","display_name":"AUC","score":0.46299999952316284}],"concepts":[{"id":"https://openalex.org/C2777210460","wikidata":"https://www.wikidata.org/wiki/Q425490","display_name":"Indinavir","level":5,"score":0.9922592639923096},{"id":"https://openalex.org/C2778607973","wikidata":"https://www.wikidata.org/wiki/Q422652","display_name":"Rifampicin","level":3,"score":0.935197651386261},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.866928219795227},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6848169565200806},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6547427773475647},{"id":"https://openalex.org/C97320921","wikidata":"https://www.wikidata.org/wiki/Q718753","display_name":"Drug interaction","level":3,"score":0.4814728796482086},{"id":"https://openalex.org/C2781069245","wikidata":"https://www.wikidata.org/wiki/Q12204","display_name":"Tuberculosis","level":2,"score":0.4727526605129242},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.3787391185760498},{"id":"https://openalex.org/C2776452011","wikidata":"https://www.wikidata.org/wiki/Q311463","display_name":"Sida","level":4,"score":0.24129992723464966},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.14477115869522095},{"id":"https://openalex.org/C2780727368","wikidata":"https://www.wikidata.org/wiki/Q1928978","display_name":"Viral disease","level":3,"score":0.07564207911491394},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.04191744327545166}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000904","descriptor_name":"Antibiotics, Antitubercular","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D004347","descriptor_name":"Drug Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012293","descriptor_name":"Rifampin","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D019469","descriptor_name":"Indinavir","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D019540","descriptor_name":"Area Under Curve","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1211/0022357011775488","doi":"https://doi.org/10.1211/0022357011775488","is_oa":false,"landing_page_url":"https://doi.org/10.1211/0022357011775488","pdf_url":null,"source":{"id":"https://openalex.org/S118304455","display_name":"Journal of Pharmacy and Pharmacology","issn_l":"0022-3573","issn":["0022-3573","2042-7158"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmacy and Pharmacology","raw_type":"journal-article"},{"id":"pmid:11291758","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11291758","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of pharmacy and pharmacology","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9922999739646912}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":6,"referenced_works":["https://openalex.org/W2098202090","https://openalex.org/W2149568397","https://openalex.org/W2318289184","https://openalex.org/W2325718923","https://openalex.org/W2397863685","https://openalex.org/W2917102420"],"related_works":["https://openalex.org/W2101188719","https://openalex.org/W2007793443","https://openalex.org/W2034227821","https://openalex.org/W2318266472","https://openalex.org/W2092534615","https://openalex.org/W2063914923","https://openalex.org/W1606729453","https://openalex.org/W2141817082","https://openalex.org/W1998765853"],"abstract_inverted_index":{"Indinavir,":[0],"an":[1,5,16,36,163],"antiretroviral":[2],"agent,":[3],"has":[4,27,162],"influence":[6],"on":[7,68,93,118,166],"the":[8,31,46,51,64,69,148,167],"pharmacokinetics":[9,70],"of":[10,18,25,35,38,45,54,58,66,71,90,151,169],"other":[11],"drugs":[12,49],"by":[13,155],"acting":[14],"as":[15],"inhibitor":[17],"cytochrome":[19],"P450-mediated":[20],"drug":[21],"metabolism.":[22],"The":[23,56,124],"incidence":[24],"tuberculosis":[26],"increased":[28,154],"dramatically":[29],"in":[30,73,79],"past":[32],"decade":[33],"because":[34],"epidemic":[37],"HIV":[39],"infection.":[40],"Rifampicin":[41,112],"is":[42],"still":[43],"one":[44],"most":[47],"valuable":[48],"for":[50],"standard":[52],"treatment":[53],"tuberculosis.":[55],"objective":[57],"this":[59],"study":[60,76],"was":[61,77,134,141,153],"to":[62,109],"investigate":[63],"effects":[65],"indinavir":[67,101,137,146,161],"rifampicin":[72,92,128,152],"man.":[74],"Our":[75],"conducted":[78],"eleven":[80],"HIV-infected":[81],"patients.":[82],"All":[83],"patients":[84],"received":[85],"a":[86,104],"600-mg":[87],"single":[88],"dose":[89],"oral":[91,100],"day":[94,105,107,110,119,122],"1":[95,120],"and":[96,98,121],"15-":[97],"800-mg":[99],"three":[102],"times":[103],"from":[106],"2":[108],"15.":[111,123],"pharmacokinetic":[113],"studies":[114],"were":[115,130],"carried":[116],"out":[117],"results":[125],"showed":[126],"that":[127,160],"concentrations":[129],"higher":[131],"when":[132,139],"it":[133,140],"administered":[135,142],"with":[136],"than":[138],"alone.":[143],"With":[144],"concomitant":[145],"medication,":[147],"mean":[149],"AUC0-24":[150],"73%.":[156],"Therefore,":[157],"we":[158],"conclude":[159],"inhibitory":[164],"effect":[165],"metabolism":[168],"rifampicin.":[170]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2012067775","counts_by_year":[{"year":2020,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2016-06-24T00:00:00"}
